Study of a Drug [DCVaxÂ®-L] to Treat Newly Diagnosed GBM Brain Cancer

about

Study of a Drug [DCVaxÂ®-L] to Treat Newly Diagnosed GBM Brain Cancer

Item

http://www.wikidata.org/entity/Q58844236

description

A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov

@en

klinisch onderzoek

@nl

name

Study of a Drug [DCVaxÂ®-L] to Treat Newly Diagnosed GBM Brain Cancer

@en

Study of a Drug [DCVaxÂ®-L] to Treat Newly Diagnosed GBM Brain Cancer

@nl

type

Item

label

Study of a Drug [DCVaxÂ®-L] to Treat Newly Diagnosed GBM Brain Cancer

@en

Study of a Drug [DCVaxÂ®-L] to Treat Newly Diagnosed GBM Brain Cancer

@nl

prefLabel

Study of a Drug [DCVaxÂ®-L] to Treat Newly Diagnosed GBM Brain Cancer

@en

Study of a Drug [DCVaxÂ®-L] to Treat Newly Diagnosed GBM Brain Cancer

@nl

P3098

NCT00045968

http://www.w3.org/2001/XMLSchema#string

P31

clinical trial

P4135

http://www.w3.org/2001/XMLSchema#decimal

P6153

Case Western Reserve University

Indiana University – Purdue University Indianapolis

University of Alabama at Birmingham

University of North Carolina at Chapel Hill

University of Michigan

Georgetown University

Cleveland Clinic

New York University

University of South Florida

University of Florida

P8363

interventional study

P921

cancer immunotherapy